title: [Study on preventive and therapeutic effects of astragali radix on denervated tibial muscle atrophy in rats].
abstract: OBJECTIVE
  To study the effect of Astragali Radix on the denervated tibial muscle atrophy in rats, and discuss its mechanism.
  
  
  METHODS
  Totally 60 SPF-grade Sprague-Dawley rats were selected in the common peroneal nerve crush model, and then randomly divided into 6 groups: Astragali Radix high-dose, medium-dose, low-dose groups, the Mecobalamin group, the model group, and the sham operation group. They were administered with drugs after the operation. At 18 d, the pathological section staining and morphological analysis were performed. The wet-weight ratio and section area of tibial muscles were also measured. The real-time fluorescence quantification was adopted to detect the differential expression between Angptl4 and PI3K genes.
  
  
  RESULTS
  (1) Wet-weight ratio: The wet-weight ratio in Astragali Radix high-dose, medium-dose groups was much higher than that in the model group (P < 0.05 or P < 0.01). (2) Section area: The sham operation group was higher, with regular morphology; Whereas the model group showed significant decrease, with chaotic structure and obvious connective tissue proliferation; Astragali Radix groups and the mecobalamin group showed relatively small section areas, with chaotic structure and unobvious connective tissue proliferation. Compared with the model group, Astragali Radix groups showed significant increase (P < 0.01). (3) Motor end plate: The sham operation group was in uniform brownish black color and oval or round shape; Astragali Radix medium-dose and high-dose group and the mecobalamin group showed rough line edges; Astragali Radix medium-dose and low-dose groups and the model group showed decline in the number, with irregular morphology, rough line edges and a light color. (4) Angptl4 and PI3K: Compared with the model group, the Astragali Radix high-dose group showed significant increase (P < 0.05).
  
  
  CONCLUSIONS
  Astragali Radix has a significant effect in preventing and treating denervated tibial muscle atrophy. It may delay the muscle atrophy by increasing Angptl4 and PI3K gene expressions.
authors: Lan
authors: L
authors: Zhou
authors: Xiao-Yun
authors: XY
authors: Mei
mesh_terms: D000075803:Angiopoietin-Like Protein 4; D042682:Angiopoietins / Q000235:genetics; D000818:Animals; D027883:Astragalus Plant; D027885:Astragalus propinquus / Q000737:chemistry*; D004305:Dose-Response Relationship, Drug; D004365:Drugs, Chinese Herbal / Q000494:pharmacology* / Q000627:therapeutic use; D005786:Gene Expression Regulation / Q000187:drug effects; D008297:Male; D009133:Muscular Atrophy / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology / Q000517:prevention & control*; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D013977:Tibia
chemical_list: D000075803:Angiopoietin-Like Protein 4; D042682:Angiopoietins; D004365:Drugs, Chinese Herbal; D019869:Phosphatidylinositol 3-Kinases; C528241:ANGPTL4 protein, rat; C027492:Huang Qi